Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Alan G. Ramsay, PhD, Gullu Gorgun, PhD, Tobias A.W. Holderried, David Zahrieh, MS, Fenglong Liu, PhD, John Quackenbush, PhD, Carlo M. Croce, MD, John G. Gribben, MD, DSc

Blood (2008) 112 (11): 30.

https://doi.org/10.1182/blood.V112.11.30.30

Published: 2008

Journal Articles

Costs of Complications after Allogeneic Myeloablative Stem Cell Transplantation.

Akiko M. Saito, MD, PhD, Corey Cutler, MD, MPH, FRCPC, David Zahrieh, MS, Vincent T. Ho, MD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Stephanie J. Lee, MD, MPH

Blood (2006) 108 (11): 2977.

https://doi.org/10.1182/blood.V108.11.2977.2977

Published: 2006

Journal Articles

CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL.

Gullu Gorgun, PhD, Tobias A.W. Holderried, Rifca Ledieu, MD, David Zahrieh, MS, John G. Gribben, MD,DSc.

Blood (2005) 106 (11): 50.

https://doi.org/10.1182/blood.V106.11.50.50

Published: 2005

Journal Articles

Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation.

Akiko M. Saito, MD, PhD, Corey Cutler, MD, MPH, FRCPC, David Zahrieh, MS, Robert J. Soiffer, MD, Vincent T. Ho, MD, Edwin P. Alyea, MD, Joseph H. Antin, MD, Stephanie J. Lee, MD, MPH

Blood (2005) 106 (11): 1797.

https://doi.org/10.1182/blood.V106.11.1797.1797

Published: 2005

Journal Articles

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Vassiliki Rizouli, MD, David Zahrieh, MS, Gullu Gorgun, PhD, Tobias A.W. Holderried, Carlo Croce, MD, John G. Gribben, MD, DSc

Blood (2004) 104 (11): 180.

https://doi.org/10.1182/blood.V104.11.180.180

Published: 2004

NARROW

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Costs of Complications after Allogeneic Myeloablative Stem Cell Transplantation.

CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL.

Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation.

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Email alerts

ASH Publications

American Society of Hematology

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Costs of Complications after Allogeneic Myeloablative Stem Cell Transplantation.

CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL.

Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation.

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only